National Research Corp is primarily active in the healthcare industry. With years of expertise and a comprehensive suite of research solutions, National Research Corp provides valuable insights and improvement strategies to healthcare organizations. Their services aim to enhance patient satisfaction, manage reputation, and drive overall healthcare excellence. With a strong focus on the healthcare sector, National Research Corp has established itself as a trusted partner for healthcare providers, delivering data-driven solutions to improve quality, safety, and patient experience.

The main competitors of National Research Corp in the market include Press Ganey Holdings Inc., NRC Health Inc., and Advisory Board Company.

National Research Corp is a leading provider of analytics and insights to healthcare organizations. With a rich history spanning over three decades, the company has established itself as a trusted partner in delivering transformative solutions. National Research Corp's journey began in 1981, when it was founded by Samuel K. Hazen and Michael D. Hays to address the emerging need for healthcare quality measurement and improvement. Since then, National Research Corp has consistently pioneered innovative technologies and data-driven approaches to help healthcare providers enhance patient experiences, achieve operational excellence, and drive positive outcomes. Today, their comprehensive suite of services continues to empower healthcare institutions worldwide, making National Research Corp a respected global leader in the industry.

National Research Corp (NRC) has achieved significant milestones throughout its history. These include becoming a leading provider of patient satisfaction surveys and market research to healthcare organizations. NRC has built a reputation for delivering actionable insights and innovative solutions. The company has expanded its services globally and established strategic partnerships with major healthcare organizations. NRC's commitment to excellence has earned it numerous industry accolades, such as being named one of the "Best Places to Work in Healthcare" multiple times. With its strong track record and industry recognition, National Research Corp continues to be a trusted partner for healthcare organizations worldwide.

National Research Corp primarily operates in the United States. With its headquarters in Lincoln, Nebraska, the company provides performance measurement and improvement services to healthcare organizations across all 50 states. National Research Corp's dedication to serving the US healthcare industry has positioned it as a leading provider of patient satisfaction surveys, market insights, and quality improvement solutions.

National Research Corp (NRC) represents a strong set of values and corporate philosophy. With a commitment to excellence, NRC upholds integrity, transparency, and accountability in all its operations. The company places great emphasis on client satisfaction and strives to provide exceptional healthcare performance measurement solutions. NRC values innovation and continuously seeks new ways to improve patient care outcomes. By leveraging advanced data analytics, NRC assists healthcare organizations in delivering high-quality services, promoting positive patient experiences, and achieving operational efficiency. NRC's corporate philosophy revolves around fostering trust and collaboration with clients, driving meaningful advancements in the healthcare industry.

8 analysts currently rate the National Research stock: 0 recommend buying, 3 holding and 5 selling. For 2026, analysts expect National Research to generate revenue of 142.60 M USD and earnings per share of 0.34 USD.

National Research Analyst Price Targets 2026

Converted at the current exchange rate, the National Research share trades at 18.29 EUR (21.19 USD).

The National Research share (NRC) is listed on 3 stock exchanges, including: NASDAQ (NRC), Frankfurt (NR1A.F), München (NR1A.MU).

National Research Corp (NRC) is a leading company in the field of health care performance tools. Their business model is to provide their customers, mainly in the healthcare industry, with tools and data to improve patient experience, increase compliance with regulations, and enhance profitability. NRC works with various sectors, including hospitals, nursing homes, medical groups, rehabilitation centers, hospices, pharmacies, and health insurers. NRC offers a wide range of products and services to meet their customers' needs. The key products include: - MIND: A digital platform that provides healthcare executives with a 360-degree view of their organization. With MIND, users can access data to make informed decisions, respond to changes, and optimize their business. - Market Insights: A tool that allows customers to gather, analyze, and make informed decisions from data on their patients and competitors. Market Insights helps customers maximize their growth potential and better understand their competitive environment. - Transparency: An online rating system based on patient feedback. Transparency allows customers to collect, measure, and analyze feedback from their patients to improve their patient experience and remain competitive. - Family Experience: A module that enables nursing homes to enhance the experience of patients and family members. Family Experience helps customers increase their home stay rate and improve financial performance. In addition to providing products and services, NRC offers a variety of services to help their customers increase efficiency and profitability. This includes training healthcare staff to optimize the use of NRC's tools. NRC also offers professional services to optimize their customers' business operations, such as consulting services or data analysis. NRC's business model is focused on helping their customers achieve their goals and optimize their business operations. The company earns revenue through the sale of products, services, and additional features. Most of NRC's products are subscription-based and typically billed annually to customers. Overall, NRC's business model is centered around offering data-driven tools and services to their healthcare customers to increase profitability and improve their success in patient experience and their environment. NRC is an established company that has been operating for over 30 years and serves customers in the USA, Canada, and the Middle East.

The expected revenue of National Research is 142.60 M USD. This figure is based on current financial data and reflects the company's business performance.

The expected profit of National Research is 7.39 M USD. The net profit reflects the company's profitability after deducting all expenses.

The price-to-earnings ratio (P/E) of National Research is currently 62.52. The P/E ratio compares the current share price to the earnings per share and helps investors assess the valuation of the National Research stock.

The price-to-sales ratio (P/S) of National Research is currently 3.24. The P/S ratio compares the market capitalization to the annual revenue and serves as a valuation metric for the National Research stock.

The Eulerpool Quality Score for National Research is 3/10.

The ISIN of National Research is US6373722023. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.

The WKN of National Research is A1WYXP. The WKN (Wertpapierkennnummer) is a six-digit German security identification number.

The ticker of National Research is NRC. The ticker symbol is used to trade National Research shares on the stock exchange.

Over the past 12 months, National Research paid a dividend of 0.52 USD . This corresponds to a dividend yield of about 2.45 %. For the coming 12 months, National Research is expected to pay a dividend of 0.64 USD.

The current dividend yield of National Research is 2.45 %.

National Research pays a dividend, distributed in the months of , , , .

National Research paid dividends every year for the past 21 years.

For the upcoming 12 months, dividends amounting to 0.64 USD are expected. This corresponds to a dividend yield of 3.02 %.

National Research is assigned to the 'Health' sector.

To receive the latest dividend of National Research from amounting to 0.16 USD, you needed to have the stock in your portfolio before the ex-date on .

The last dividend was paid out on .

In the year 2025, National Research distributed 0.48 USD as dividends.

The dividends of National Research are distributed in USD.